NICE chief: NHS faces 'startling costs' from new treatments

By Sharon Brennan2018-06-07T05:58:00

The NHS faces a “material challenge” to fund new personalised drugs and deal with the “startling costs” of new medical technology, says the chief executive of the National Institute for Health and Care Excellence.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here